Breast and cervical cancer screening tests provided by a US program for women with low incomes plummeted by more than 80% in April 2020.
CDC researchers measuring COVID-19’s impact on screenings by the National Breast and Cervical Cancer Early Detection Program found:
- Breast and cervical cancer screenings in April 2020 fell by 87% and 84%, respectively, compared with 5-year averages for the month.
- Breast cancer screenings for American Indian/Alaskan Native women fell the most—by 98%.
- Cervical cancer screenings for Asian Pacific Islander women dropped by 92%.
Screenings began to increase in May and June 2020.